Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming

FO Adeshakin, AO Adeshakin, LO Afolabi, D Yan… - Frontiers in …, 2021 - frontiersin.org
The attachment of cells to the extracellular matrix (ECM) is the hallmark of structure–function
stability and well-being. ECM detachment in localized tumors precedes abnormal …

The double-edge sword of autophagy in cancer: from tumor suppression to pro-tumor activity

R Chavez-Dominguez, M Perez-Medina… - Frontiers in …, 2020 - frontiersin.org
During tumorigenesis, cancer cells are exposed to a wide variety of intrinsic and extrinsic
stresses that challenge homeostasis and growth. Cancer cells display activation of distinct …

Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression

S Sui, S Xu, D Pang - Pharmacology & therapeutics, 2022 - Elsevier
Breast cancer has become a serious threat to women's health. Cancer progression is mainly
derived from resistance to apoptosis induced by procedures or therapies. Therefore, new …

Emerging roles of ceramides in breast cancer biology and therapy

P Pal, GE Atilla-Gokcumen, J Frasor - International Journal of Molecular …, 2022 - mdpi.com
One of the classic hallmarks of cancer is the imbalance between elevated cell proliferation
and reduced cell death. Ceramide, a bioactive sphingolipid that can regulate this balance …

Recent insights into the effects of metabolism on breast cancer cell dormancy

S Bartlome, CC Berry - British Journal of Cancer, 2022 - nature.com
Breast cancer (BC) remains the most common cancer, as well as the leading cause of
cancer mortality in women worldwide. Approximately 30% of patients with early-stage BC …

UGCG overexpression leads to increased glycolysis and increased oxidative phosphorylation of breast cancer cells

N Schömel, L Gruber, SJ Alexopoulos, S Trautmann… - Scientific reports, 2020 - nature.com
The only enzyme in the glycosphingolipid (GSL) metabolic pathway, which produces
glucosylceramide (GlcCer) de novo is UDP-glucose ceramide glucosyltransferase (UGCG) …

Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancer

A Jaggupilli, S Ly, K Nguyen, V Anand, B Yuan… - British journal of …, 2022 - nature.com
Background Metabolic stress resulting from nutrient deficiency is one of the hallmarks of a
growing tumour. Here, we tested the hypothesis that metabolic stress induces breast cancer …

Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells

Z Li, L Jiang, J Ni, Y Xu, F Liu, W Liu, S Wang… - Acta Pharmacologica …, 2023 - nature.com
UDP-glucose ceramide glucosyltransferase (UGCG) is the first key enzyme in
glycosphingolipid (GSL) metabolism that produces glucosylceramide (GlcCer). Increased …

[HTML][HTML] Ceramide glycosylation and related enzymes in cancer signaling and therapy

Z Li, L Zhang, D Liu, C Wang - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Ceramides, the core of the sphingolipid metabolism, draw wide attention as tumor
suppressor, and act directly on mitochondria to trigger apoptotic cell death. Ceramide-based …

Influence of glycosphingolipids on cancer cell energy metabolism

N Schömel, G Geisslinger, MS Wegner - Progress in lipid research, 2020 - Elsevier
A growing number of studies describe a connection between glycosphingolipids (GSLs) and
glutamine metabolism, glucose metabolism and mitochondrial dysfunction in cancer cells …